期刊文献+

酶抑制剂类抗病毒药物的研究进展 被引量:1

Recent research progress in the antiviral enzyme inhibitors
暂未订购
导出
摘要 综述了逆转录酶抑制剂、DNA聚合酶抑制剂、RNA聚合酶抑制剂、蛋白酶抑制剂、神经氨酸酶抑制剂、S-腺苷L-高半胱氨酸水解酶抑制剂、单磷酸次黄嘌呤核苷脱氢酶抑制剂和HIV-1整合酶抑制剂的研究进展。
出处 《中国生化药物杂志》 CAS CSCD 2002年第6期319-321,324,共4页 Chinese Journal of Biochemical Pharmaceutics
  • 相关文献

参考文献19

  • 1Graeme M. The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapy[J]. Drugs,2001,61(1):19-26.
  • 2De CE. Antiviral drugs : current state of the art[J]. J Clin Virol,2001,22(1):73-89.
  • 3Jarvis B. Lamivudine FD:A review of its therapeutic potential in chronic hepatitis B[J].Drugs, 1999,58(1):101-141.
  • 4魏文青,王明霞.抗病毒药物的分子靶标[J].国外医学(药学分册),2001,28(5):266-270. 被引量:7
  • 5Brent EK, Paul C, William H, et al.Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks [J].Antiviral Research,2000,45:19-32.
  • 6Buti M, Morral S, Sanchez F, et al.High-dose interferon-alpha2b plus ribavirin for retreatment of interferon-nonresponsive patients infected with genotype 1 hepatitis C virus[J]. Dig Dis Sci,2001,46(11):2396-2400.
  • 7Fontana RJ, Walsh J, Moyer CA, et al.High-dose interferon alfa-2b and ribavin in patients previously treated with interferon:results of a prospective,randomized,controlled trial[J].J Clin Gastroenterol,2002,34(2):177-182.
  • 8Santagostino E, Rumi MG, Rivi M,et al.Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapy[J]. Blood,2002,99(3):1089-1091.
  • 9Cassone A, Tacconelli E, De Bernardis F,et al. Antiretroviral therapy with protease inhibitors has an early,immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects[J]. J Infect Dis ,2002,185(2):188-195.
  • 10Yoshimura K, Kato R, Kavlick MF, et al. A potent human immunodeficiency virus type 1 protease inhibitor,UIC-94003(TMC-126),and selection of a novel (A28S) mutation in the protease active site[J]. J Virol,2002,76(3):1349-1358.

二级参考文献9

  • 1Jing N,J Biol Chem,2000年,275卷,28期,21460页
  • 2Jing N,J Biol Chem,2000年,275卷,5期,3421页
  • 3Reddy M V R,J Med Chem,1999年,42卷,1901页
  • 4Farnet C M,Antimicrob Agents Chemother,1998年,42卷,9期,2245页
  • 5Mc Dougall B,Antimicrob Agents Chemother,1998年,42卷,1期,140页
  • 6Neamati N,J Med Chem,1998年,41卷,3202页
  • 7Neamati N,J Med Chem,1997年,40卷,942页
  • 8Nicklaus M C,J Med Chem,1997年,40卷,920页
  • 9Zhao H,J Med Chem,1997年,40卷,1186页

共引文献6

同被引文献3

引证文献1

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部